Behind every CAR T program is a real cost structure, staffing, drug stocking, and around-the-clock monitoring, that Dr. Graff ...

T-cell therapy, access remains a significant challenge, particularly because the treatment is still largely conce ...

Agreement includes pre-payment commitments for product sales and distribution of the second-generation multi-cytokine-based HCW11-006 for use as ...

At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to ...

Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with ...

CAR T therapies face scalability challenges. An eXmoor consultant explores how synthetic approaches using lipid nanoparticles ...

T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down ...

Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting System We developed an 8-year, monthly cycle Markov ...

Thanks in part to the revolution cell therapy brought to treating blood cancers, the modality is now showing promise in some ...